ORLANDO, Fla. — The American Association for Cancer Research will recognize leaders in the minority cancer community with the Minority-Serving Institution Faculty Scholars in Cancer Research Awards. The 36 recipients will be honored at the AACR 102nd Annual Meeting 2011, held April 2-6.
The Minority-Serving Institution Faculty Scholars in Cancer Research Awards are given to scientists who are working at the level of assistant professor or above at a minority-serving institution and who are engaged in meritorious basic, clinical, translational or epidemiological cancer research. Minority-serving institutions include historically black colleges and universities, Hispanic-serving institutions, tribal colleges and universities and other post-secondary institutions as defined by the U.S. Department of Education.
The award is intended to increase the scientific knowledge base of faculty members at minority-serving institutions, to encourage them in their research and to assist in inspiring their students to pursue careers in cancer research. It is supported by a grant from the National Cancer Institute's Cancer to Reduce Cancer Health Disparities.
The recipients of the 2011 Minority-Serving Institution Faculty Scholars in Cancer Research Awards include:
- Antonio T. Baines, Ph.D., North Carolina Central University, Durham, N.C.
Abstract #256. Downregulation of Pim-3 kinase inhibits cell growth and chemosensitizes pancreatic cancer cells to gemcitabine
- Hirendra N. Banerjee, M.D., Ph.D., Elizabeth City State University, Elizabeth City, N.C.
Abstract #4939. Analysis of micro RNA status in brain cancer glioblastoma multiforme
- Brandi Brandon Knight, Ph.D., Morehouse School of Medicine, Atlanta, Ga.
- Iona C. Cheng, Ph.D., University of Hawaii, Honolulu, Hawaii
Abstract #3760. Associations of risk variants for 20 different malignancies with colorectal cancer in a multiethnic population
Abstract #2755. Association of established risk variants for obesity and type-2 diabetes with dietary intake in the Multiethnic Cohort Study
Abstract #884. Pleiotropic effects on lung cancer of genetic susceptibility variants identified for other malignancies: The multiethnic cohort
Abstract #4732. Cis-expression QTL analysis of established risk variants for colorectal cancer
- Vivian Colon-Lopez, Ph.D., M.P.H., University of Puerto Rico Medical Science Campus, San Juan, Puerto Rico
Abstract #1929. Incidence and mortality rates of penile cancer among men in Puerto Rico and the United States
- Charles desBordes, Ph.D., City University of New York, Brooklyn, N.Y.
Abstract #4069. 2-deoxyglucose and compound C reversed acidification but enhanced growth inhibition in colon cancer cells treated with metformin and phenformin
- Ibtissam Echchgadda, Ph.D., UT Health Science Center, San Antonio, Texas
Abstract #361. Calcitriol-dependent induction of the human sulfotransferase SULT2B1 in the prostate: Implication in the growth inhibition of prostate cancer
- Kristina G. Flores, Ph.D., University of New Mexico, Albuquerque, N.M.
Abstract #891. The association of single nucleotide polymorphisms in folate metabolism genes with hypermethylation patterns in smokers at high risk for lung cancer
- Hernan Flores-Rozas, Ph.D., Florida A&M University, Tallahassee, Fla.
Abstract #4475. Inhibition of aminoacid biosynthetic pathways lead to increase sensitivity to anthracyclines in Saccharomyces cerevisiae
- Shanchun Guo, Ph.D., Morehouse School of Medicine, Atlanta, Ga.
Abstract #825. Leptin signaling disruption prevents DMBA-induced mammary tumors in lean and diet-induced-obesity (DIO) mice
Abstract #1009. Leptin induces Src/Gbr2/Gab2/STAT3 activation and Rac-1 crosstalk to regulate VEGF/VEGFR2 in breast cancer
Abstract #4086. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin regulation of VEGF/VEGFR-2 in breast cancer
- Ali B. Ishaque, Ph.D., University of Maryland Eastern Shore, Princess Anne, Md.
- Stan Ivey, Ph.D., Delaware State University, Dover, Del.
Abstract #5268. CXCR4 and P-glycoprotein N-glycan patterning in developing cancer cells
- Khosrow Kashfi, Ph.D., City University of New York Medical School, New York, N.Y.
Abstract #3128. Hydrogen sulfide-releasing NSAIDs inhibit the growth of cultured human cancer cells: A general property and evidence of a tissue type-independent effect
Abstract #1349. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo
Abstract #807. Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo
Abstract #4608. Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression
Abstract #1353. Hydrogen sulfide-releasing naproxen inhibits HT-29 human colon cancer cell growth: Modulation of NF-κB
Abstract #5560. All three positional isomers of acetyl salicylic acids are equally potent in inhibiting colon cancer cell growth: Differences in mode of COX inhibition
- Ward G. Kirlin, Ph.D., Morehouse School of Medicine, Atlanta, Ga.
Abstract #1850. Benzyl isothiocyanate causes proteasome-mediated degradation of aryl hydrocarbon receptor in Hepa1c1c7 cells
- Addanki Pratap Kumar, Ph.D., UT Health Science Center, San Antonio, Texas
Abstract #3544. Jak/Stat signaling: A potential target for pancreatic cancer management
Abstract #4951. 2-Methoxyestradiol (2-ME2) induces microRNA alterations in prostate cancer cells: Role for miRs in 2-ME2-induced biological effects
Abstract #851. Interactions among transcription factors as a potential mechanism for inhibiting castrate-resistant prostate cancer (CRPCa) in transgenic adenocarcinoma of mouse prostate (TRAMP) through regulation of FLIP
- Dong Liang, Ph.D., Texas Southern University, Houston, Texas
Abstract #4669. Genetic variations in telomere pathway genes and ovarian cancer risk, survival and treatment response
- Amosy E. M'Koma, Ph.D., Meharry Medical College, Nashville, Tenn.
- Patrick M. Martin, Ph.D., North Carolina A&T State University, Greensboro, N.C.
Abstract # 2933. Inhibition of MAPK signaling prevents Fra-1-mediated CD44 expression in human brain tumor cells
- Magaly Martinez-Ferrer, Ph.D., University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
Abstract #391. Inflammatory mediators of prostate cancer metastasis
Abstract #1929. Incidence and mortality rates of penile cancer among men in Puerto Rico and the United States
- Ana P. Ortiz Martinez, M.P.H., Ph.D., University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
Abstract #1929. Incidence and mortality rates of penile cancer among men in Puerto Rico and the United States
- Sederick C. Rice, Ph.D., University of Arkansas at Pine Bluff, Pine Bluff, Ark.
- Checo J. Rorie, Ph.D., North Carolina A&T State University, Greensboro, N.C.
Abstract #2141. The differential apoptotic responses of normal breast cells versus luminal and triple negative breast cancer cells to chemotherapeutic agents
- Pothana Saikumar, Ph.D., UT Health Science Center, San Antonio, Texas
Abstract #5179. TMEPAI, a negative regulator of Smad signaling switches tumor suppressive TGF- β to a tumor promoter in breast tumorigenesis
- Amos M. Sakwe, Ph.D., Meharry Medical College, Nashville, Tenn.
Abstract #2119. Role of annexin A6 in anchorage-independent growth of invasive breast cancer cells
- Temesgen Samuel, D.V.M., Ph.D., Tuskegee Univ. College of Vet. Medicine, Tuskegee, Ala.
Abstract #2005. Modulation of tumor suppressor gene DNA-methylation by quercetin and dietary indoles
- Shengmin Sang, Ph.D., North Carolina A&T State University Center for Excellence in Post-Harvest Technologies, Kannapolis, N.C.
Abstract #4617. Bioactive phytochemicals in wheat bran for colon cancer prevention
- Pedro G. Santiago-Cardona, Ph.D., Ponce School of Medicine, Ponce, Puerto Rico
Abstract #4025. The retinoblastoma protein regulates cell adhesion: Implications for lung cancer progression
- Anjana D. Saxena, Ph.D., City University of New York Brooklyn College, Brooklyn, N.Y.
Abstract #2967. Nucleolin phosphorylation by CK2 modulates its role in cell cycle checkpoint activation
- Shailesh Singh, Ph.D., Morehouse School of Medicine, Atlanta, Ga.
Abstract #5257. Expression and functional role of CXCR5 and CXCL13 in non-small cell lung carcinoma (NSCLC)
Abstract #940. Expression and functional role of CCR9 in lung cancer
- Chung Seog Song, Ph.D., UT Health Science Center, San Antonio, Texas
Abstract #361. Calcitriol-dependent induction of the human sulfotransferase SULT2B1 in the prostate: Implication in the growth inhibition of prostate cancer
- Maribel Tirado-Gómez, M.D., University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
Abstract #2766. DNA methylation status of MLH1, p16 and SOCS1 in Puerto Rican patients with acute myeloid leukemia
- Ratna K. Vadlamudi, Ph.D., University of Texas Health Science Center, San Antonio, Texas
Abstract #1464. Significance and therapeutic potential of PELP1 axis in ER-negative breast cancer
Abstract #73. PELP1 is a novel reader of chromatin modifications: Implications in cancer progression
Abstract #1733. Therapeutic significance of ERα—PELP1 axis in blocking endocrine therapy resistance
Abstract #2297. ERβ agonists reduce letrozole resistant breast cancer cell growth and diminish aromatase expression and activity
- Cynthia M. van Golen, Ph.D., Delaware State University, Dover, Del.
Abstract #2085. Reactive oxygen species promote signaling in neuroblastoma cells
Abstract #2924. IGF-IR inhibition induces MAPK signaling in prostate carcinoma cells
Abstract #2425. Mechanisms of neuroblastoma metastasis to bone
Abstract #1435. Analyzing the role of CXCR and IGF-IR in modulating actin dynamics in neuroblastoma cells
- Pablo E. Vivas-Mejía, Ph.D., University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
Abstract #1706. Microarray analysis of gene expression reveals that several mTOR related genes are upregulated in cisplatin resistant ovarian cancer cells
Abstract #937. Molecular dynamics of SrcS17 activation in chronic stress-induced tumor growth
Abstract #1735. Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer
Abstract #1618. Erythropoietin meets a new receptor
Abstract #4457. In search of a novel EPO receptor: The clinical significance of the Eph connection
- Clement G. Yedjou, Ph.D., Jackson State University, Jackson, Miss.
Abstract #1322. Molecular mechanisms of high glucose-induced toxicity in human breast adenocarcinoma (Mcf-7) cells
Abstract #4209. Genotoxic effects of arsenic trioxide-induced oxidative stress in human hepatocellular carcinoma (HepG2) cells
- Beatriz Zayas, Ph.D., Universidad Metropolitana, San Juan, Puerto Rico
Abstract #4474. Cellular effects of fluorescent quinolinium drugs on normal lymphoblast and A431 carcinoma cells Abstract #1342. Effects of the plasticizer metabolite 2 ethyl-1-hexanol on human lymphoblast cells
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.